Vivek Jain
Washington University in St. Louis
14 Papers
125 Citations
Vivek Jain is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Obstructive sleep apnea & Sleep apnea. The author has an hindex of 5, co-authored 11 publications.
Chat about Author
Papers
Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases.
TL;DR: This review summarizes currently available information on the evidence for and against the occurrence of oxidative stress in OSA and the role of reactive oxygen species in cardiovascular changes associated with OSA.
244
Sleepiness, sleeplessness, and pain in end-stage renal disease: distressing symptoms for patients.
TL;DR: In this paper, sleep disorders are common in end-stage renal disease (ESRD) patients treated with dialysis and are associated with patients' perceptions of quality of life, assessed by diverse measures, as well as depressive affect.
77
Regulation of Bcl-xL expression in lung vascular smooth muscle.
Yuichiro J. Suzuki,Hiroko Nagase,Chi-Ming Wong,Shilpashree Vinod Kumar,Vivek Jain,Ah-Mee Park,Regina M. Day +6 more
TL;DR: Inducers of pulmonary hypertension enhance anti-apoptotic Bcl-x(L) gene transcription, which can be suppressed by targeting gata4 gene transcription and established that SNP targets the 250 proximal region of the gATA4 promoter and suppresses its gene transcription.
38
Plasma levels of retinoids, carotenoids and tocopherols in patients with mild obstructive sleep apnoea
Regina M. Day,Ismael A. Matus,Yuichiro J. Suzuki,Kyung-Jin Yeum,Jian Qin,Ah-Mee Park,Vivek Jain,Tunay Kuru,Guangwen Tang +8 more
TL;DR: The hypothesis that plasmas from OSA patients contain altered levels of retinoids, carotenoids and tocopherols was tested and it was found that these levels were higher than previously thought.
17
Reassessing the effects of continuous positive airway pressure (CPAP) on arterial stiffness and peripheral blood derived CD34+ progenitor cells in subjects with sleep apnea.
Cleyton C. Domingues,Fiona J. Dore,Alexander Cho,Neeki Ahmadi,Yana Kropotova,Nabanita Kundu,Naji Younes,Vivek Jain,Sabyasachi Sen +8 more
TL;DR: The findings suggest that 3-month CPAP intervention does not show statistical significant increase in CD34+ cell number and function, in mostly moderate to severe OSA subjects; however, it did demonstrate a positive trend and CPAP therapy, did help improve arterial stiffness parameter.